Amgen Europe B.V.
- C10 - Agentes modificadores de los lípidos
- REPATHA CARTRIDGE solution for injection 420 mg
- REPATHA PREFILLED PEN solution for injection 140 mg
- REPATHA PREFILLED SYRINGE solution for injection 140 mg
- H05 - Homeostasis del calcio
- MIMPARA film-coated tablet 30 mg
- MIMPARA film-coated tablet 60 mg
- MIMPARA film-coated tablet 90 mg
- PARSABIV solution for injection 10 mg/2 ml
- PARSABIV solution for injection 2.5 mg/0.5 ml
- PARSABIV solution for injection 5 mg/1 ml
- L01 - Antineoplásicos
- IMLYGIC solution for injection 1 000 000 PFU/1 ml
- IMLYGIC solution for injection 100 000 000 PFU/1 ml
- KANJINTI powder for solution for infusion 150 mg
- KANJINTI powder for solution for infusion 420 mg
- KYPROLIS powder for solution for infusion 10 mg
- KYPROLIS powder for solution for infusion 30 mg
- KYPROLIS powder for solution for infusion 60 mg
- MVASI concentrate for solution for infusion 100 mg/4 ml
- MVASI concentrate for solution for infusion 400 mg/16 ml
- VECTIBIX concentrate for solution for infusion 100 mg/5 ml
- VECTIBIX concentrate for solution for infusion 400 mg/20 ml
- L03 - Inmunoestimulantes
- NEULASTA solution for injection 6 mg/0.6 ml
- NEUPOGEN solution for injection 300 µg(30 M IU)/1 ml
- L04 - Inmunosupresores
- KINERET solution for injection 100 mg/0.67 ml
- M05 - Preparados para el tratamiento de enfermedades óseas
- PROLIA PRE FILLED SYRINGE solution for injection 60 mg/1 ml
- XGEVA solution for injection 120 mg/1.7 ml